155 related articles for article (PubMed ID: 2201426)
1. Immunohistochemical study of melanocytic nevus and malignant melanoma with monoclonal antibodies against S-100 subunits.
Cho KH; Hashimoto K; Taniguchi Y; Pietruk T; Zarbo RJ; An T
Cancer; 1990 Aug; 66(4):765-71. PubMed ID: 2201426
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical demonstration of S-100 protein and melanoma-associated antigens in melanocytic nevi.
Paul E; Cochran AJ; Wen DR
J Cutan Pathol; 1988 Jun; 15(3):161-5. PubMed ID: 2456315
[TBL] [Abstract][Full Text] [Related]
3. Melanoma cell heterogeneity. A study of two monoclonal antibodies compared with S-100 protein in paraffin sections.
Duray PH; Palazzo J; Gown AM; Ohuchi N
Cancer; 1988 Jun; 61(12):2460-8. PubMed ID: 3365669
[TBL] [Abstract][Full Text] [Related]
4. The differential reactivity of benign and malignant nevomelanocytic lesions with mouse monoclonal antibody TNKH1.
Nakanishi T; Hashimoto K
Cancer; 1987 Apr; 59(7):1340-4. PubMed ID: 3545436
[TBL] [Abstract][Full Text] [Related]
5. [Contribution of monoclonal antibody HMB45 in the histopathologic diagnosis of melanoma].
Pluot M; Joundi A; Grosshans E
Ann Dermatol Venereol; 1990; 117(10):691-9. PubMed ID: 1705764
[TBL] [Abstract][Full Text] [Related]
6. Detection of S-100 protein as an aid to the identification of melanocytic tumors.
Cochran AJ; Wen DR; Herschman HR; Gaynor RB
Int J Cancer; 1982 Sep; 30(3):295-7. PubMed ID: 6752046
[TBL] [Abstract][Full Text] [Related]
7. [Immunohistochemical analysis of ras gene expression in human melanomas and melanocytic nevi].
Yasuda H
Hokkaido Igaku Zasshi; 1989 May; 64(3):243-53. PubMed ID: 2670726
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical demonstration of S100 protein in malignant melanoma and pigmented nevus, and its diagnostic application.
Nakajima T; Watanabe S; Sato Y; Kameya T; Shimosato Y; Ishihara K
Cancer; 1982 Sep; 50(5):912-8. PubMed ID: 6807528
[TBL] [Abstract][Full Text] [Related]
9. Concurrent Ki-67 and p53 immunolabeling in cutaneous melanocytic neoplasms: an adjunct for recognition of the vertical growth phase in malignant melanomas?
Kaleem Z; Lind AC; Humphrey PA; Sueper RH; Swanson PE; Ritter JH; Wick MR
Mod Pathol; 2000 Mar; 13(3):217-22. PubMed ID: 10757331
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical studies of conjunctival nevi and melanomas.
Jakobiec FA; Bhat P; Colby KA
Arch Ophthalmol; 2010 Feb; 128(2):174-83. PubMed ID: 20142539
[TBL] [Abstract][Full Text] [Related]
11. Proto-oncogene c-kit expression in malignant melanoma: protein loss with tumor progression.
Montone KT; van Belle P; Elenitsas R; Elder DE
Mod Pathol; 1997 Sep; 10(9):939-44. PubMed ID: 9310959
[TBL] [Abstract][Full Text] [Related]
12. Human monoclonal antibodies that distinguish cutaneous malignant melanomas from benign nevi in fixed tissue sections.
Imam A; Mitchell MS; Modlin RL; Taylor CR; Kempf RA; Kan-Mitchell J
J Invest Dermatol; 1986 Feb; 86(2):145-8. PubMed ID: 3528308
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical localization of the Ca2+ binding S100 proteins in normal human skin and melanocytic lesions.
Böni R; Burg G; Doguoglu A; Ilg EC; Schäfer BW; Müller B; Heizmann CW
Br J Dermatol; 1997 Jul; 137(1):39-43. PubMed ID: 9274623
[TBL] [Abstract][Full Text] [Related]
14. S-100 protein in melanocytic tumors. An immunohistochemical investigation of benign and malignant melanocytic tumors and metastases of malignant melanoma and a characterization of the antigen in comparison to human brain.
Kindblom LG; Lodding P; Rosengren L; Baudier J; Haglid K
Acta Pathol Microbiol Immunol Scand A; 1984 Jul; 92(4):219-30. PubMed ID: 6496075
[TBL] [Abstract][Full Text] [Related]
15. Typical, dysplastic, congenital, and Spitz nevi: a comparative immunohistochemical study.
Palazzo J; Duray PH
Hum Pathol; 1989 Apr; 20(4):341-6. PubMed ID: 2703228
[TBL] [Abstract][Full Text] [Related]
16. Ex vivo quality-switched ruby laser irradiation of cutaneous melanocytic lesions: persistence of S-100-, HMB-45- and Masson-positive cells.
Kopera D; Hohenleutner U; Stolz W; Landthaler M
Dermatology; 1997; 194(4):344-50. PubMed ID: 9252755
[TBL] [Abstract][Full Text] [Related]
17. Interleukin (IL)-1 alpha- and -1 beta-, IL-6-, and tumor necrosis factor-alpha-like immunoreactivities in human common and dysplastic nevocellular nevi and malignant melanoma.
Ahmed AA; Nordlind K; Hedblad M; Lagerholm B; Schultzberg M; Lidén S
Am J Dermatopathol; 1995 Jun; 17(3):222-9. PubMed ID: 8599429
[TBL] [Abstract][Full Text] [Related]
18. [Distribution of melanoma-associated antigens (HMB 45 and S 100) in benign and malignant melanocytic tumors of the conjunctiva].
Steuhl KP; Rohrbach JM; Knorr M
Klin Monbl Augenheilkd; 1991 Sep; 199(3):187-91. PubMed ID: 1753671
[TBL] [Abstract][Full Text] [Related]
19. Role of In Vivo Reflectance Confocal Microscopy in the Analysis of Melanocytic Lesions.
Serban ED; Farnetani F; Pellacani G; Constantin MM
Acta Dermatovenerol Croat; 2018 Apr; 26(1):64-67. PubMed ID: 29782304
[TBL] [Abstract][Full Text] [Related]
20. Nucleolar organizer regions in malignant melanoma and melanocytic nevi. Comparison of two counting methods.
Di Gregorio C; Losi L; Annessi G; Botticelli A
Am J Dermatopathol; 1991 Aug; 13(4):329-33. PubMed ID: 1928617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
